"Exemptia is a Fingerprint Match of Adalimumab. The Data is now Published."
"Exemptia is Approved in
Rheumatoid Arthritis
,
Ankylosing Spondylitis
,
Psoriatic Arthritis
,
Juvenile Idiopathic Arthritis,
Plaque Psoriasis
,
Hidradenitis Suppurativa
, Crohn’s Disease, Paediatric Crohn's Disease and Ulcerative Colitis”
Select Condition
Rheumatoid Arthritis (RA)
Ankylosing Spondylitis (AS)
Psoriatic Arthritis (PsA)
Juvenile Idiopathic Arthritis (JIA)
Plaque Psoriasis
Hidradenitis Suppurativa (HS)
Crohn's Disease & Ulcerative Colitis (CD & UC)
Open/Close Menu
Skip to content
About Adalimumab
Important Safety Instructions
Medication Guide
Instructions for Use
Voice of Exemptia
Health Care Professionals
Downloads
Home
|
Important Links
|
Downloads
Medication Guide
Instructions for Use
Patient Education Booklet
© 2017 Cadila Healthcare Ltd. All Rights Reserved. |
↑